The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience

BRCA1,TP53, andCHEK2germline mutations in uterine serous carcinoma

(2012) Kathryn P. Pennington et al.   CANCER

Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities

(2012) Xi Lin et al.   HEARING RESEARCH

Germline RAD51C mutations confer susceptibility to ovarian cancer

(2012) Chey Loveday et al.   NATURE GENETICS

Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies

(2011) Benjamin Meder et al.   Circulation-Cardiovascular Genetics

Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility

(2011) He-ping Xiang et al.   EUROPEAN JOURNAL OF CANCER

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

(2011) T. Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background

(2008) J H Mao et al.   ONCOGENE